Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma
NCT03274349 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2018-10-16
Summary
The objective or the trial is to study the influence of a combined therapy involving protein-rich individualized nutritional therapy and highly effective muscle training via personalized whole-body electromyostimulation exercise on muscle mass, muscle functionality, physical capability, fatigue and quality of life in patients with esophageal and bronchial carcinoma in advanced or metastatic stage.
Conditions
- Cancer of Esophagus
- Cancer, Lung
Interventions
- PROCEDURE
-
whole body electromyostimulation exercise
whole body electromyostimulation exercise training twice a week for 20 min each, bipolar, 85 Hz, intermittent pulse/pause, pulse width 350 µsec
- PROCEDURE
-
protein-rich nutrition therapy
protein-rich nutrition therapy with an objective of reaching 1,2 to 1,5 g protein/kg body weight and day
Sponsors & Collaborators
-
University of Erlangen-Nürnberg Medical School
lead OTHER
Principal Investigators
-
Yurdaguel Zopf, Prof. · University Erlangen Nuremberg Medical School
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-17
- Primary Completion
- 2021-03-31
- Completion
- 2021-03-31
Countries
- Germany
Study Locations
More Related Trials
-
Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction Cancer
NCT01786278 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Proton Beam Therapy in the Treatment of Esophageal Cancer
NCT03482791 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiation Dose Escalation in Esophageal Cancer
NCT03082586 ·Status: COMPLETED ·Phase: NA
-
Intermittent Oro-esophageal Tube Feeding in Late Dysphagia for Nasopharyngeal Carcinoma
NCT06248879 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
NCT03286920 ·Status: UNKNOWN
-
Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma
NCT01752205 ·Status: UNKNOWN ·Phase: PHASE3
-
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction
NCT00107341 ·Status: COMPLETED ·Phase: PHASE2
-
The Intensive Nutritional Support in Esophageal Cancer Undergoing Neoadjuvant Therapy
NCT07067359 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma
NCT02446574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Proton Beam Therapy to Treat Esophageal Cancer
NCT02023541 ·Status: TERMINATED ·Phase: PHASE1
-
Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma
NCT04380480 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC
NCT02647125 ·Status: COMPLETED ·Phase: PHASE2
-
PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal Cancer
NCT03113214 ·Status: COMPLETED ·Phase: NA
-
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
NCT03535207 ·Status: UNKNOWN ·Phase: NA
-
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
NCT02642809 ·Status: COMPLETED ·Phase: PHASE1
-
Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer
NCT06840704 ·Status: RECRUITING ·Phase: PHASE3
-
Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
NCT00022139 ·Status: COMPLETED ·Phase: PHASE2
-
Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma
NCT00964080 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma
NCT02399306 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)
NCT06138223 ·Status: RECRUITING ·Phase: NA
-
Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer
NCT01670409 ·Status: COMPLETED ·Phase: PHASE2
-
Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.
NCT02745561 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Esophageal Cancer
NCT00041262 ·Status: UNKNOWN ·Phase: PHASE3
-
Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004867 ·Status: COMPLETED ·Phase: NA